Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma's patent monopoly is stealing your paycheck - and driving up costs
A tsunami of healthcare costs is crashing into the budgets of U.S. businesses. Each new wave forces employers to devote more resources to healthcare and fewer to employee wages, benefits, and investments for growth. Beyond the workplace, families…
Trump's Pick for Surgeon General Holds Investments in Tech, Tobacco, Fast Food, and Big Pharma
Nicole Saphier, President Donald Trump's pick to be Surgeon General, released her financial disclosure forms this week in the lead-up to her confirmation hearing on Sept. 16. The forms, posted online Thursday, contain an odd mix of just about…
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
The iShares Global Healthcare ETF (IXJ -0.13%) offers broad sector diversification and lower volatility, while the State Street SPDR S&P Pharmaceuticals ETF (XPH -0.73%) provides concentrated exposure to U.S. drugmakers. Investors seeking…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Rating of 'Moderate Buy' by Brokerages
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have received an average rating of 'Moderate Buy' from the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. One research analyst has…
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Strong-Buy
Royalty Pharma (NASDAQ:RPRX - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a 'buy' rating to a 'strong-buy' rating in a research note issued to investors on Saturday, Wall Street Zen reports. How Royalty…
Avalyn Pharma (NASDAQ:AVLN) Rating Increased to Hold at Wall Street Zen
Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports. AVLN has…
California State Teachers Retirement System Increases Holdings in Royalty Pharma PLC $RPRX
California State Teachers Retirement System lifted its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5,065.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission…
Ascentage Pharma Group International (NASDAQ:AAPG) Sets New 12-Month Low - Here's What Happened
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) shares hit a new 52-week low during trading on Friday. The company traded as low as $16.03 and last traded at $16.25, with a volume of 2375 shares traded. The…
Dutch ambassador visits survivors of fatal Swiss coach accident
Switzerland juggles fighting crime against threat to tech-privacy industry Read more: Switzerland juggles fighting crime against threat to tech-privacy industry US-Canada trade war escalates, 9/11 25 years on, and a medical first involving a pig…
Orion Corporation: Acquisition of own shares during week 37, 2026
Orion Corporation: Acquisition of own shares during week 37, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 September 2026 until no later than…
Alkermes: A Slow-Burning Buy Prospect On Orexin-Agonist Promise (NASDAQ:ALKS)
Alkermes plc is upgraded from Hold to Buy, driven by robust revenue growth, pipeline momentum, and strategic positioning in sleep and CNS disorders. Acquisition of Avadel and Lumryz launch propel >20% revenue growth in 2026; adjusted EBITDA…
CDC declares cyclospora outbreak over
After nearly 13,000 cases and more than 500 hospitalizations, the Centers for Disease Control and Prevention (CDC) said there is no longer any risk of contracting cyclosporiasis from the source linked to the outbreak. David Paul Morris/Bloomberg…
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
Investors choosing between Amgen (AMGN -0.86%) and Revolution Medicines (RVMD -2.07%) must weigh established cash flows against high-stakes clinical potential. Which of these healthcare players is the better addition to your portfolio today? Amgen…
Vuelta a Espana stage 19: Dunbar wins mountain duel with Buitrago, Mas inches closer to overall victory
Enric Mas is one day closer to the biggest victory of his career after comfortably defending the Vuelta a España red jersey on the longest stage of this year's race, a 211km route in the mountains above the Costa del Sol. Pinarello Q36.5's…
Punjab talks drugs again. Its children are still paying the price
This week, that future claimed another victim. Gulzar Singh, a labourer from Sangrur, consumed Celphos tablets after allegedly being threatened by the local sarpanch and others for questioning a sitting minister about rampant drug abuse in the…
Receive a Daily briefing on Pharma Industry News
Get Started